St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor

Phase 1

Completed

Conditions: Malaria

Interventions: Drug: SJ733
Drug: Cobicistat

First Posted Date: 2016-01-22

Last Posted Date: 2019-01-02

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 44

Registration Number: NCT02661373

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Influenza Virus Vaccine Plus Vitamin A and D Supplements for Prevention of Respiratory Virus Infections in Children

Phase 2

Completed

Conditions: Healthy Participants

Interventions: Biological: Influenza virus vaccine
Dietary Supplement: Vitamins A and D
Other: Placebo

First Posted Date: 2016-01-07

Last Posted Date: 2019-10-29

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 87

Registration Number: NCT02649192

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Medical Treatment Decision Making Using Adaptive Conjoint Analysis

Terminated

Conditions: Cancer
Lymphoma
Brain Tumor
Solid Tumor
Leukemia

First Posted Date: 2015-11-18

Last Posted Date: 2021-12-21

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 25

Registration Number: NCT02608307

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy

Completed

Conditions: Leukemia
Lymphoma

First Posted Date: 2015-09-30

Last Posted Date: 2024-08-15

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 137

Registration Number: NCT02564484

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I

Phase 1

Active, not recruiting

Conditions: Acute Lymphoblastic Leukemia

Interventions: Drug: ITMHA
Drug: Dexamethasone
Drug: Mitoxantrone
Drug: Pegaspargase
Drug: Asparaginase Erwinia Chrysanthemi
Drug: Bortezomib
Drug: Vorinostat
Drug: Cyclophosphamide
Drug: Mercaptopurine
Drug: Methotrexate
Drug: Leucovorin Calcium
Drug: Cytarabine
Drug: Etoposide
Drug: Vincristine

First Posted Date: 2015-09-17

Last Posted Date: 2024-01-18

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 50

Registration Number: NCT02553460

Locations: 🇺🇸
Children's Hospital of Orange County, Orange, California, United States
🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Rady Children's Hospital and Health Center, San Diego, California, United States

and more 14 locations

Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Recruiting

Conditions: Solid, Liquid, Central Nervous System Tumors

Interventions: Other: Study Introduction Visit
Other: Informed Consent Visit
Other: Informed Consent Follow-Up Visit
Other: Return of Results Conversation
Other: Return of Results Follow-Up Visits
Procedure: Blood Sample
Procedure: Skin Biopsy

First Posted Date: 2015-08-21

Last Posted Date: 2024-10-08

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 2500

Registration Number: NCT02530658

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Phase 2

Terminated

Conditions: Leukemia, B-Cell
Lymphoma, Non-Hodgkin's
Acute Lymphoblastic Leukemia
Leukemia, T-Cell

Interventions: Drug: Dexamethasone
Drug: Panobinostat
Drug: Liposomal vincristine
Drug: Mitoxantrone
Drug: Peg-asparaginase
Drug: Bortezomib
Drug: Intrathecal Triples
Drug: High-dose methotrexate
Drug: 6-Mercaptopurine
Drug: High-dose cytarabine
Drug: Nelarabine
Drug: Cyclophosphamide
Drug: Etoposide
Drug: Clofarabine

First Posted Date: 2015-08-10

Last Posted Date: 2019-04-03

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 3

Registration Number: NCT02518750

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Impact of Resistance Training-Protein Supplementation on Lean Muscle Mass in Childhood Cancer Survivors

Not Applicable

Completed

Conditions: Cancer

Interventions: Other: Educational handouts
Other: Resistance training
Dietary Supplement: Supplementation
Other: Placebo

First Posted Date: 2015-07-17

Last Posted Date: 2018-07-17

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 130

Registration Number: NCT02501460

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Assessing Blood Pressure Remotely in Childhood Cancer Survivors

Completed

Conditions: Hypertension

Interventions: Device: iHealth Wireless Blood Pressure Monitor

First Posted Date: 2015-06-19

Last Posted Date: 2016-09-15

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 60

Registration Number: NCT02476162

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia

Not Applicable

Terminated

Conditions: Hodgkin Lymphoma
Lymphoma, Non-Hodgkin's
Leukemia

Interventions: Other: PedsQL Cancer Module
Other: PedsQL Multidimensional Fatigue Scale
Device: Biodex System 3 Dynamometer
Device: Jamar Hydraulic Hand Dynamometer
Other: Sit and Reach Test
Other: Test of Motor Proficiency
Other: Verbal Numeric Pain Scale

First Posted Date: 2015-06-16

Last Posted Date: 2017-03-08

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 2

Registration Number: NCT02473523

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy